MPR - Medical Professionals Reference

  • Home
  • MPR - Medical Professionals Reference

MPR - Medical Professionals Reference MPR provides daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.

Check out our app for up-to-date drug reference information and clinical tools at your fingertips.

Study finds tirzepatide superior to intensified conventional care for mean changes in hemoglobin A1c, weight, and waist ...
28/05/2026

Study finds tirzepatide superior to intensified conventional care for mean changes in hemoglobin A1c, weight, and waist circumference.

Tirzepatide superior to ICC for mean changes in hemoglobin A1c, weight, and waist circumference

The FDA has extended the review for an investigational advanced breast cancer Tx Camizestrant after the Advisory Committ...
27/05/2026

The FDA has extended the review for an investigational advanced breast cancer Tx Camizestrant after the Advisory Committee voted 6 to 3 against recommending approval.

The Agency will review supplemental data from AstraZeneca to address ODAC concerns regarding overall survival benefit, trial design interpretation, and cardiovascular safety.

Trial finds single consolidated infusion of Briumvi comparable to current schedule of multiple doses.
27/05/2026

Trial finds single consolidated infusion of Briumvi comparable to current schedule of multiple doses.

The study demonstrated a favorable safety profile, with the consolidated single-infusion regimen showing fewer infusion reactions compared to the reference regimen.

NIAID officials barred from communicating with the WHO. They can attend virtual WHO meetings in small groups and only in...
27/05/2026

NIAID officials barred from communicating with the WHO. They can attend virtual WHO meetings in small groups and only in a “listening capacity."

The moves are an outgrowth of Republican frustration with WHO’s handling of the COVID-19 pandemic.

More uncertainty at HHS as the head of the National Institute for Allergy and Infectious Diseases steps down. The reason...
26/05/2026

More uncertainty at HHS as the head of the National Institute for Allergy and Infectious Diseases steps down. The reason for the departure is unknown.

The reason for his departure remains unclear

FDA approves first treatment for chronic hepatitis delta virus.
26/05/2026

FDA approves first treatment for chronic hepatitis delta virus.

Hepcludex is the first FDA-approved treatment for chronic hepatitis delta virus.

A 20-year-old woman presents with a recurrent, well-defined patch on the right side of her chest that appeared earlier i...
21/05/2026

A 20-year-old woman presents with a recurrent, well-defined patch on the right side of her chest that appeared earlier in the day. Can you make the correct diagnosis? Take this week's Clinical Challenge!

A 20-year-old woman presents with a recurrent, well-defined patch on the right side of her chest that appeared earlier in the day. Can you make the correct diagnosis?

A late-stage study of fianlimab and cemiplimab as first-line therapy for unresectable or metastatic melanoma missed its ...
20/05/2026

A late-stage study of fianlimab and cemiplimab as first-line therapy for unresectable or metastatic melanoma missed its primary efficacy endpoint.

A late-stage study of fianlimab and cemiplimab as first-line therapy for unresectable or metastatic melanoma missed its primary efficacy endpoint.

Amazon customers may have received expired emergency contraception. Several lots of expired levonorgestrel were delivere...
19/05/2026

Amazon customers may have received expired emergency contraception. Several lots of expired levonorgestrel were delivered between January and April.

The FDA has warned that multiple lots of Amazon’s emergency contraceptive were delivered past their expiration dates, posing a significant risk of reduced efficacy and unintended pregnancy.

High-risk of cross-border spread for current ebola outbreak, declares WHO. The US withdrew from WHO under the Trump admi...
19/05/2026

High-risk of cross-border spread for current ebola outbreak, declares WHO. The US withdrew from WHO under the Trump administration earlier this year.

Patients have reportedly experienced classic Ebola disease symptoms like fever, headache, vomiting, severe weakness, abdominal pain, nosebleeds and vomiting blood, the CDC said.

Address


Website

Alerts

Be the first to know and let us send you an email when MPR - Medical Professionals Reference posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MPR - Medical Professionals Reference:

Shortcuts

  • Want your business to be the top-listed Media Company?

Share